EXPRESSION OF STREPTOMYCES-PEUCETIUS GENES FOR DOXORUBICIN RESISTANCEAND AKLAVINONE 11-HYDROXYLASE IN STREPTOMYCES-GALILAEUS ATCC-31133 AND PRODUCTION OF A HYBRID ACLACINOMYCIN

Citation
Ck. Hwang et al., EXPRESSION OF STREPTOMYCES-PEUCETIUS GENES FOR DOXORUBICIN RESISTANCEAND AKLAVINONE 11-HYDROXYLASE IN STREPTOMYCES-GALILAEUS ATCC-31133 AND PRODUCTION OF A HYBRID ACLACINOMYCIN, Antimicrobial agents and chemotherapy, 39(7), 1995, pp. 1616-1620
Citations number
19
Categorie Soggetti
Pharmacology & Pharmacy",Microbiology
ISSN journal
00664804
Volume
39
Issue
7
Year of publication
1995
Pages
1616 - 1620
Database
ISI
SICI code
0066-4804(1995)39:7<1616:EOSGFD>2.0.ZU;2-3
Abstract
The aklavinone 11-hydroxylase gene and two doxorubicin resistance gene s cloned from Streptomyces peucetius subsp. caesius ATCC 27952 were in troduced into doxorubicin-sensitive Streptomyces galilaeus ATCC 31133, an aclacinomycin producer. The doxorubicin resistance genes drrA and drrB endowed S. galilaeus with high-level resistance to doxorubicin, i ndicating that the resistance mechanism for doxorubicin might be diffe rent from that for aclacinomycin A. Transformation of S. galilaeus ATC C 31133 with plasmid pMC213 containing the aklavinone 11-hydroxylase g ene (dnrF) resulted in the production of many red pigments. A new meta bolite was purified, and the position of the newly introduced hydroxyl group was determined. This result indicated that the aklavinone 11-hy droxylase gene was stably expressed in S. galilaeus ATCC 31133 and tha t it gave rise to a hybrid aclacinomycin A which showed highly specifi c in vitro cytotoxicity against leukemia and melanoma cell lines.